Although defined by the absence of estrogen receptor, progesterone receptor, and ERBB2 expression, genomic analyses have revealed intrinsic triple-negative breast cancer subtypes, including basal-like (BL1 and BL2), mesenchymal, luminal androgen receptor, and immunomodulatory subtypes.16 This evidence concerns the gene PGR and triple-negative breast carcinoma.